Skip to content

MTOUCH

Absorbed by REDPHARMA KBO/BCE: BE 0597.829.806 subsidiary of REDPHARMA

Overview

Lifetime

9 annual accounts with figures on one time axis
peak €342,713 (2021)
€89,692▲ 35.3%
lowest -€60,429 (2023)
-€60,429▼ €57,455
peak €526,015 (2022)
€465,587▼ 11.5%
€149,708▼ 17.1%
peak 2.7 FTE (2018)
2 FTEunchanged
Board12 names since 2015
3 directorsClotilde Ghysselinckx and 2 others
Owners3 names in the annual accounts
100%REDPHARMA and 1 other
Documentsfilings and deeds
15-07-202416 days before the deadline
2023abbreviated format
Gross margin from €66,272 to €89,692Loss of €60,429Powers of attorney: Patrick Van Dooren and Bert Kindt 04-05Resignation: Frank Swaelens (director) 13-02Debts from €180,629 to €149,708

Key points

from the 2023 annual accounts, the last ones filed

Result

-€60,429 ▼ 1,932%
-€2,9702022-€60,4002023

The result fell in 2023 from -€2,973 to -€60,429.

Filings

9 annual accounts 7 late
AprilJune31 JulyOctober20152020

The 2018 accounts came latest: 153 days after the end of the period.

No score

Board and ownership

CG
Director, since 30-06-2022
CV
Director, since 30-06-2022
VE
Vanderhaeghen Emmanuel
Director, since 01-02-2023
Board & ownership

Recent changes

Merger: absorbed by REDPHARMA General meeting of 15-03-2024 · Gazette deed
Merger proposal: to be absorbed by Redpharma Redpharma holds all the shares · Gazette deed
Resignation: Frank Swaelens (director) Appointment: Emmanuel Vanderhaegen (director) · Director discharge: Frank Swaelens · General meeting of 01-02-2023 · Gazette deed
New statutory auditor Mazars Bedrijfsrevisoren - Mazars Réviseurs d'Entreprises appointed, KPMG Réviseurs d'Entreprises resigned · Permanent representatives: Dominic Rousselle and Peter Lenoir · General meeting of 14-07-2022 · Gazette deed
All 25 events

Official details

Source: KBO
Status
Absorbed by REDPHARMAmerger by absorption, April 2024
Activity
“De vennootschap heeft tot voorwerp, voor eigen rekening en voor rekening van derderı, in…” (deed in Dutch)From the articles, 24 activitiesNo NACE code in the KBO yet
Joint committee
200Auxiliary committee for white-collar workers · annual accounts 2023
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2023

€89,692▲ 35.3%
≈ €250,000estimated
€60,429▲ 20×
€465,587▼ 11.5%
€615,295▼ 12.9%
Employeeson 31-12-2023
2=
Filing
Filed on 15-07-2024
Financials

Companies linked to MTOUCH

Insights on MTOUCH

Absorbed by REDPHARMA in April 2024. The last annual accounts are for financial year 2023.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2023

abbreviated format, filed on 15-07-2024, 16 days before the deadline
€89,692
▲ 35.3%
-€68,313
▼ €65,973
-€65,840
▼ €65,921
-€57,956
▼ €57,404
75.7%
▲ 1.2 percentage points
4.10
▲ 0.21

Money flows

no detail for 2023

Balance sheet

balance sheet total €615,295 on 31-12-2023
What the company ownsHow it is paid for

in euro

in euro

Staff

€76,556

Staff costs divided by the average number of full-time equivalents.

people who joined people who left

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202320222021202020192018201720162015
Balance sheet: assets
20/58 615,295706,645752,656500,248530,570565,358492,511394,903157,704
21/28 1,5043,9766,3988,13517,86819,61329,69432,6774,700
21 6232,4934,3206,1208,1861,5852,9024,2214,700
22/27 8801,4842,0782,0159,68318,02926,70928,373-
23 ---531,7993,5465,2936,777-
24 8801,4842,0781,9623,7306,1758,9554,980-
28 ------8484-
29/58 613,791702,668746,258492,113512,702545,744462,817362,226153,004
40/41 279,339228,437333,038307,941360,876377,670310,483248,52279,606
40 221,056192,924333,038307,941357,009343,095306,135248,52279,606
41 58,28435,513--3,86834,5754,347--
54/58 334,355474,231413,220183,362151,244167,493152,335113,70473,398
490/1 97--810581581---
Balance sheet: equity and liabilities
10/49 615,295706,645752,656500,248530,570565,358492,511394,903157,704
10/15 465,587526,015516,589279,827273,612198,741179,00141,7016,685
10/11 18,60018,6006,2006,2006,2006,2006,2006,2006,200
100 ----18,60018,60018,60018,60018,600
101 ----12,40012,40012,40012,40012,400
13 1,8601,8601,8601,8601,8601,8601,8601,860485
130/1 1,8601,8601,8601,860-----
130 ----1,8601,8601,8601,860485
1311 1,8601,8601,8601,860-----
14 445,127505,555508,529271,767265,552190,681170,94133,641-
17/49 149,708180,629236,067220,420256,958366,616313,510353,202151,019
17 -----4,8739,63312,722-
170/4 -----4,8739,63312,722-
42/48 149,708180,629217,286220,084256,958361,743287,877247,62546,862
42 ----4,4103,5903,0892,937-
44 111,512145,436145,321183,421187,581255,155176,666189,24125,114
440/4 111,512145,436145,321183,421187,581255,155176,666189,24125,114
46 -----2,200---
45 38,19635,19371,96536,66364,922100,797108,12255,44721,748
450/3 11,42122,50065,63233,20258,46892,875102,86049,06221,748
454/9 26,77512,6936,3323,4616,4547,9235,2626,384-
47/48 ----44----
492/3 -018,781336-116,00092,855104,157
Income statement
70 --1.1m671,375761,467910,371---
76A ---7711,567----
9900 89,69266,272342,71392,231206,238208,146283,134112,8322,297
60/61 --772,572601,090559,370708,741---
62 153,11265,98537,85056,23497,290130,97755,60139,334-
630 2,4732,4223,1679,73410,74511,13011,0369,1541,055
631/4 2,4200-16,4804,838-12,30029,117---
640/8 02064,0151,6137311,0931,9212,059348
66A -08,11710,4038,553----
9901 -68,313-2,340306,0459,410101,21935,830214,57662,284894
75/76B 12,73345714,7381,95910,2562,142-1951
75 12,73345714,7381,95910,2562,142-1951
65/66B 2,4576901,1801,2461,3031,58992975610
65 2,4576901,1801,2461,3031,58992975610
9903 -58,037-2,573319,60310,123110,17236,383213,64761,547935
67/77 2,39240082,8413,90835,30116,64376,34626,531450
9904 -60,429-2,973236,7616,21574,87119,740137,30135,016485
9905 -60,429-2,973236,7616,21574,87119,740137,30135,016485
Appropriation of the result
9906 445,127505,555508,529271,767265,552190,681170,94135,016485
14P 505,555508,529271,767------
691/2 -------1,375485
6920 -------1,375485
Social balance sheet
9087 2211.21.92.71.30.8-
Hours worked1013 3,3882,0591,7212,0033,2224,4201,9141,398-
Document PDFPDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 12 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2023 (PDF), filed on 15-07-2024.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2023 abbreviated format 15-07-2024 2024-00260460 PDF
31-12-2022 abbreviated format 31-08-2023 2023-00426721 PDF
31-12-2021 full format 13-06-2022 2022-20071215 PDF
31-12-2020 full format 02-08-2021 2021-46700442 PDF
31-12-2019 full format 13-10-2020 2020-61600362 PDF
31-12-2018 full format 31-12-2019 2019-77900547 PDF
31-12-2017 micro format 27-09-2018 2018-65800226 PDF
31-12-2016 micro format 16-08-2017 2017-45800007 PDF
31-12-2015 abbreviated format 12-08-2016 2016-42800372 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202320222021202020192018201720162015
-65,84081309,21119,143111,96446,959225,61271,4391,949
-57,956-552239,92815,94985,61630,869148,33744,1701,540
001,43009,0001,1328,05437,1315,755
-139,87661,011229,85832,118-16,24815,15838,63040,306-
464,083522,039528,972272,029255,744184,002174,940114,600106,142
--27.7%1.4%13.3%3.9%---
75.7%74.4%68.6%55.9%51.6%35.2%36.3%10.6%4.2%
4.103.893.432.242.001.511.611.463.26
0.320.340.460.790.941.841.758.4722.59
-13.0%-0.6%45.8%2.2%27.4%9.9%76.7%84.0%7.3%
-9.8%-0.4%31.5%1.2%14.1%3.5%27.9%8.9%0.3%
-26.800.12over 100------
--110 days167 days171 days138 days---
--69 days111 days122 days131 days---

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Social balance sheet

Item31-12-202331-12-202231-12-2021
Employees at the balance-sheet date221
full-time221
part-time00-
in full-time equivalents221
221
On a permanent contract221
Joined-1-
Left-0-

Source: social balance sheet in the 2021 to 2023 annual accounts

Investments

fixed assets acquired
Item202320222021
Tangible fixed assets--€1,430
€2,473€2,422€3,167

Source: notes to the 2021 to 2023 annual accounts (statement of fixed assets)

Insights on MTOUCH

The operating result for 2023 is a loss of €68,313, larger than the loss of €2,340 in 2022. It is the lowest result since 2015.

Debt's share of the balance-sheet total falls from 25.6% to 24.3%. Equity and debt are lower.

Board & ownership

Last board

3 directors, last change in 2023
Director
since 30-06-2022 term without a fixed end
listed in the 2023 annual accounts, filed on 15-07-2024
Director
since 30-06-2022 term without a fixed end
listed in the 2023 annual accounts, filed on 15-07-2024
Vanderhaeghen Emmanuel
Director
since 01-02-2023
listed in the 2023 annual accounts, filed on 15-07-2024
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“De besluiten van het bestuursorgaan kunnen worden genomen bij eenparig schriftelijk akkoord van de bestuurders. De besluiten van het…”
deed of 26-08-2022

Office holders in the KBO →

Mandates through the years

12 names, the dashed line is today
Vanderhaeghen Emmanuel
Director
mediaxe
Director
REDPHARMA
Director
ROSSEL & Cie
Director
Noëlle Lucas
Statutory auditor
BoardEarliermandate already running before its first mentionend not dated
Mandates as a list
  • Clotilde Ghysselinckx
    • Director, from 30-06-2022 to date
  • Clément Vanthournhout
    • Director, from 30-06-2022 to date
  • Vanderhaeghen Emmanuel
    • Director, from 01-02-2023 to date
  • Emmanuel Vanderhaegen
    • Director, from before 31-12-2022, no longer listed in the 2023 annual accounts
  • Frank Swaelens
    • Director, appointed by deed of 24-08-2022, until 13-02-2023
  • Forvis Mazars Réviseurs d’Entreprises
    • Statutory auditor, appointed by deed of 07-09-2022, no longer listed in the 2023 annual accounts
  • Bernard Marchant
    • Director, until 24-08-2022
  • mediaxe
    • Director, from 09-02-2015 to 24-08-2022
  • REDPHARMA
    • Director, until 24-08-2022
  • ROSSEL & Cie
    • Director, until 24-08-2022
  • KPMG Réviseurs d'Entreprises BV/SRL
    • Statutory auditor, from 30-07-2021, no longer listed in the 2023 annual accounts
  • Noëlle Lucas
    • Statutory auditor, appointed by deed of 22-08-2019, until 13-01-2022

See the board, name and registered office on a given date →

Control

Parent
Equity €1.4m
Profit €2.2m in 2025 (profit €1.5m in 2024)
Checked score 94
100%
This company
MTOUCH
Equity €465,587
Loss €60,429 in 2023

Further up the chainIQVIA Solutions Belgium 100%IQVIA AG 99.99%IQVIA HOLDINGS INC. US consolidates

and 1 other shareholder

Capital

Contribution
€18,600
Shares
630
Contribution per share
€29.52
Equity per share
€739 in 2023
Source
2023 annual accounts

Owners through the years

as the annual accounts name them
IQVIA HOLDINGS INC. US
consolidates
consolidates until 2021
Owners as a list

Source: parent in its own accounts, lists of holdings in the owners' accounts

Articles of association

deed of 26-08-2022 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Wednesday of June at 10:30
Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
“Één of meer vereffenaars, alle machten artikel 2:87 Wetboek van vennootschappen en verenigingen zonder bijzondere machtiging”

Shareholders

2 owners

Owners 2

Capital transactions

Shareholders according to the deeds
Stated in the deed deed of 05-02-2024 ↗
Capital over time
  1. 26-08-2022 Capital stated in the deed · 630 shares

Network & group

Group

REDPHARMA has 1 direct subsidiary (2023 accounts), the bar shows equity in euros
ParentREDPHARMA1 holding, 1 country 2023 accounts

Belgium 1 Equity Result

  • BE MTOUCHno longer active €465,587 result -€60,429

Source: list of holdings in the 2023 accounts of REDPHARMA. Every holding stands with its own latest accounts.

Acquisitions and mergers

1 transaction
Taken over by:REDPHARMA
BE 0824.819.011operation treated as a merger by absorption · Gazette deed of 14-06-2024 (4 deeds) · effective 01-04-2024

Connections & network

3 last directors
Depth

The network starts from the directors of MTOUCH. Every other company they run is a node.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Timeline

Timeline

25 events since 2015
2024
Annual accounts 2023 filed PDFabbreviated format · 16 days before the deadline
Merger: absorbed by REDPHARMAGeneral meeting of 15-03-20242 points ▸
  • General meeting, 15-03-2024
  • Accounting effect, 01-01-2024
  • The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

Merger proposal: to be absorbed by RedpharmaRedpharma holds all the shares1 point ▸
  • Redpharma holds all the shares
  • The deed holds 10 more points.

Open the deed in the Belgian Official Gazette

2023
Weakest financial year net -€60,429 The net result drops to -€60,429, the lowest from 2015 to 2023.
Annual accounts 2022 filed PDFabbreviated format · 31 days late
Powers of attorney: Patrick Van Dooren and Bert KindtBoard meeting of 15-03-20233 points ▸
  • Board meeting, 15-03-2023
  • Power of attorney, Patrick Van Dooren
  • Power of attorney, Bert Kindt
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

Resignation: Frank Swaelens (director)Appointment: Emmanuel Vanderhaegen (director) · Director discharge: Frank Swaelens · General meeting of 01-02-20234 points ▸

Open the deed in the Belgian Official Gazette

2022
New statutory auditorMazars Bedrijfsrevisoren - Mazars Réviseurs d'Entreprises appointed, KPMG Réviseurs d'Entreprises resigned · Permanent representatives: Dominic Rousselle and Peter Lenoir · General meeting of 14-07-20225 points ▸

Open the deed in the Belgian Official Gazette

Registered office moved from Brussels to ZaventemNew registered office: Da Vincilaan 7, Vlaams Gewest, 1930 Zaventem · Previous registered office: Koningsstraat 100, 1000 Brussel · General meeting of 18-08-20223 points ▸
  • General meeting, 18-08-2022
  • Registered-office move, Da Vincilaan 7, Vlaams Gewest, 1930 Zaventem
  • 630 shares
  • The deed holds 2 more points.

Open the deed in the Belgian Official Gazette

3 directors appointed, 4 resignationsResignations: Bernard Marchant, Mediaxe SRL, RedPharma SA and Rossel & Cie SA · Permanent representatives: Kristof Cannoot, Paul Moreau and Thierry Hugot · Appointments: Frank Swaelens, Clément Vanthournhout and Clotilde Ghysselinckx · General meeting of 30-06-202211 points ▸

Open the deed in the Belgian Official Gazette

Annual accounts 2021 filed PDFfull format · 48 days before the deadline
Appointment: KPMG Réviseurs d'Entreprises BV/SRL (statutory auditor)Permanent representative: Dominic Rousselle · General meeting of 30-07-20213 points ▸

Open the deed in the Belgian Official Gazette

2021
Highest result from 2015 to 2023 net €236,761 ▲3,709% The operating result of €306,045 and the net result of €236,761 are both a record.
Equity above €500,000 equity €516,589 ▲84.6% With a profit in every financial year since 2015, equity grows to €516,589.
Annual accounts 2020 filed PDFfull format · 2 days late
2020
Registered office moved from Brussels to AuderghemNew registered office: Avenue des volontaires 19-1160 Auderghem · Previous registered office: 100 Rue Royale à 1000 Bruxelles · Board meeting of 15-10-20202 points ▸
  • Board meeting, 15-10-2020
  • Registered-office move, Avenue des volontaires 19-1160 Auderghem

Open the deed in the Belgian Official Gazette

Annual accounts 2019 filed PDFfull format · 74 days late
2019
Equity above €200,000 equity €273,612 ▲37.7% With a profit in every financial year since 2015, equity grows to €273,612.
Annual accounts 2018 filed PDFfull format · 153 days late
Appointment: Noëlle Lucas (statutory auditor)General meeting of 01-06-20182 points ▸
  • General meeting, 01-06-2018
  • Auditor appointment, Noëlle Lucas (statutory auditor)

Open the deed in the Belgian Official Gazette

2018
Annual accounts 2017 filed PDFmicro format · 58 days late
2017
Equity above €150,000 equity €179,001 ▲329% With a profit in every financial year since 2015, equity grows to €179,001.
Annual accounts 2016 filed PDFmicro format · 16 days late
2016
Annual accounts 2015 filed PDFabbreviated format · 12 days late
2015
Incorporation PDF12 publications in the Belgian Official Gazette, the last on 14-06-2024

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

The registered office moved to Auderghem in 2020 and to Zaventem in 2022.12 Of the 3 current board members, 2 have served since 2022.3 In 2024 MTOUCH was absorbed by merger into REDPHARMA.4

  1. 1Belgian Official Gazette, 07-12-2020
  2. 2Belgian Official Gazette, 26-08-2022
  3. 3National Bank, annual accounts 2023
  4. 4Belgian Official Gazette, 14-06-2024

Company details

Purpose, financial year and meetings according to the articles of association

Name, seat, purpose and duration

PurposeThe purpose describes the activities the company may carry out under its articles.
“De vennootschap heeft tot voorwerp, voor eigen rekening en voor rekening van derderı, in België en in het buitenland:; De vennootschap kan…”
24 activities
  1. De vennootschap heeft tot voorwerp, voor eigen rekening en voor rekening van derderı, in België en in het buitenland:
  2. De vennootschap kan alle activiteiten verrichten betreffende het geven van lessen, opleidingen, organisatie van evenementen, conferenties, vergaderingen, seminaries, avonden, incentives, recepties, evenals alle activiteiten betreffende animatie, her- er bijscholing voor privépersoner of bedrijven rechtstreeks of onrechtstreeks in verband met haar voorwerp.
  3. De vennootschap kan eveneens de activiteiten var callceriter verrichten en alle daarmee in verband staande opdrachten en investeringen.
  4. De verhandeling (groothandel of kleinhandel), invoer, uitvoer, distributie, dienst na verkoop van alle types materieel, roerende goederer en diensten - in bovengenoemde domeiner of aridere - bestemd voor de industrie en/of openbare of private besturen.
  5. De oritwikkeling, terugkoop, verkoop, beheer, valoriserirng, huur of de toekenning van handelsfondserı, alle octrooien, licenties, fabrieksmerken en handelsmerken, know-how er andere intellectuele eigendomsrechten.
  6. Handelsvertegenwoordiging, in België en in het buitenland, van alle goederen van eender welke aard.
  7. De vennootschap kar evereens aan derden alle middelerı ter beschikking stellen (met inbegrip van de terbeschikkingstellirg van personeel) nodig voor de verwezenlijking van haar voorwerp evenals de verkoop of verhuur van alle materieel, meubilair of installaties nodig voor de productie en verspreiding van haar producter en middelen of voor de uitoefening van hun activiteit.
  8. De studie, ontwikkeling, verhandeling en verspreiding van promoties, informatieproducter en publiciteit in het algemeen, met inbegrip var wedstrijden, tombola's en getrouwheidsacties via alle beschikbare technologiekanalen.
  9. De studie, ontwikkeling, verhandeling en verspreiding van promotiemateriaal iri en rond de verkooppunten.
  10. Het begrip "materieel" omvat niet enkel promotiesupport maar eveneens alle middelen en producten van multimedia of nieuw beschikbare technologieën teneinde de zichtbaarheid te vergroten of promotie mogelijk te maken.
  11. De vennootschap kan rechtstreeks of onrechtstreeks alle activiteiten verrichten van tussenpersoon, gevolmachtigde, van financiële, commerciële, technische, administratieve of sociale verrichtingen voor rekening van derden in verband met haar voorwerp.
  12. - adviesverlening inzake organisatie en beheer van bedrijven die actief zijn in dit domein of in alle andere domeinen in de meest ruime betekenis van het woord, de vertegenwoordiging, bevordering en tussenkomst als commercieel tussenpersoon.
  13. Voor alle voornoemde activiteiten, de selectie en werving van personeel (technisch, administratief of ander personeel), zowel voor eigen rekening als voor rekening van andere bedrijven.
  14. Alle activiteiten van consultancy en/of diensten, opleiding, technische deskundigheid en bijstand, verbonden aan voornoemde domeinen evenals het organiseren van alle conferenties, vergaderingen of seminaries rechtsreeks of onrechtstreeks in verband met haar voorwerp.
  15. De vennootschap kan in deze domeinen eveneens alle onderzoeken, studies en analyses verrichten en publiceren.
  16. De vennootschap heeft eveneens tot voorwerp, op burgerlijk vlak en voor eigen rekening: alle onroerende verrichtingerı, in de meest ruime betekenis van het woord, en zo onder meer de aankoop van onroerende goederen, de verkoop, ruil, verkaveling, bouw, inrichting, promotie, verbouwing, horizontale en verticale splitsing, het brengen van onroerende goederen onder het stelsel van mede-eigendom, het bouwklaar maken ervan, de exploitatie en valorisering van onroerende goederen, evenals verhuur, onderverhuur, leasing, huuroverdracht en het beheer van bebouwde onroerende goederen waaronder deze grond en van meubilair,
  17. De valorisering en het beheer van alle onroerende goederen en in het algemeen de uitvoering van alle onroerende verrichtingen, de studie en uitvoering van alle verrichtingen in verband met alle onroerende rechten uit hun aard, door incorporatie of door bestemming.
  18. De vennootschap kan haar installaties en inrichtingen, geheel of gedeeltelijk, verhuren of in beheer geven aan derden.
  19. Onder voorbehoud van de wettelijke en reglementaire bepalingen met betrekking tot het spaarwezen, kan de vennootschap leningen aanvaarden, aangaan en toekennen, de verbintenissen van derden waarborgen, onder meer en niet exclusief, van haar dochtermaatschappijen.
  20. De vennootschap kan de financiering verwezenlijken, in alle vormen, van alle ondermemingen of verrichtingen van derden aan de hand van leningen en kredieten, borgstelling, aval, of borgstelling in het algemeen, zelfs hypothecaire borgstelling en in het algemeerı van alle mogelijke financiële verrichtingen in de ruime betekenis varı het woord, behoudens wanneer zulks door de wet is voorbehouden voor de banken, beursvennootschappen of kredietinstellingen.
  21. De vennootschap kan zich borg stellen, persoonlijke en zakelijke zekerheden stellen ten gunste van derden, natuurlijke personen of rechtspersonen, onder meer en niet-exclusief voor haar dochtermaatschappijen.
  22. De aanvaarding en uitoefening van het mandaat van zaakvoerder, bestuurder, vereffenaar en lid van het directiecomité in alle vennootschappen, ondernemingen of verenigingen.
  23. De vennootschap kan haar voorwerp verwezenlijken op alle plaatsen, manieren en volgens de modaliteiten die haar het meest geschikt lijken. Desgevallend zal de vennootschap zich voor bepaaide activiteiten conformeren aan de wetgeving die de toegang tot het beroep regelt.
  24. De vennootschap kan deze verrichtingen doen in eigen naam en voor eigen rekening, maar ook in naam en/of voor rekening van haar leden, en zelfs voor rekering van derden, onder meer in de hoedanigheid van commissionair.
deed of 05-02-2024 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 26-08-2022 (in Dutch)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaams Gewest”
deed of 26-08-2022 (in Dutch)

General meeting and financial year

Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Wednesday of June at 10:30

deed of 26-08-2022 (in Dutch)

Inactive

Absorbed by REDPHARMA in April 2024

MTOUCH is no longer in the KBO register. REDPHARMA took it over in a merger by absorption, published in the Belgian Official Gazette on 14 June 2024.

Status
Inactive
Reason
Merger by absorption"operation treated as a merger by absorption", Belgian Official Gazette, 14 June 2024 · deed
Absorbed by
REDPHARMA · 0824.819.011
Last annual accounts
financial year to 31 December 2023
Last registered office
Da Vincilaan 7, 1930 Zaventemas published on 14 June 2024
Legal form
Private limited company
First annual accounts
financial year 2015
Official KBO record